PERSPECTA

News from every angle

Back to headlines

Egyptian Group Developing Ebola Vaccine Receives Funding

An Egyptian pharmaceutical group is developing an Ebola vaccine, securing up to $16.5 million in funding from CEPI to advance the candidate as the outbreak in Congo grows.

PostShare

Sources

Showing 0 of 2 sources

No articles available in your preferred languages.

2 articles available in other languages below.